| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000037640 |
| Receipt No. | R000042910 |
| Scientific Title | Best Period to Replace or Change Plastic Stents with Self-Expandable Metallic Stents Using Multivariate Competing Risk Regression Analysis: A Single-Center Retrospective Cohort Study |
| Date of disclosure of the study information | 2019/08/09 |
| Last modified on | 2020/08/05 (Ver. 4) |
| Basic information | ||
| Public title | Best Period to Replace or Change Plastic Stents with Self-Expandable Metallic Stents Using Multivariate Competing Risk Regression Analysis: A Single-Center Retrospective Cohort Study | |
| Acronym | The best period to replace or change plastic stent to SEMS | |
| Scientific Title | Best Period to Replace or Change Plastic Stents with Self-Expandable Metallic Stents Using Multivariate Competing Risk Regression Analysis: A Single-Center Retrospective Cohort Study | |
| Scientific Title:Acronym | The best period to replace or change plastic stent to SEMS | |
| Region |
|
|
| Condition | ||
| Condition | Consecutive patients with suspected hepatobiliary-pancreatic disorders who underwent EBD attempts between January 1, 2012, and December 31, 2018, were retrospectively included in this study. Data on ERCP procedures were retrieved from the Jikei University ERCP database, with more than 6 months of follow up. | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The primary aim of this study was to determine the best period to replace or change a Plastic stent (PS) with a Self-expandable metallic stent (SEMS) in each disease, after resolving the risk factors for recurrent biliary obstruction. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The primary endpoint of the present study was the period to recurrent biliary obstruction(PRBO) in each disease.Consecutive patients with suspected hepatobiliary-pancreatic disorders who underwent EBD attempts between January 1, 2012, and December 31, 2018, were retrospectively included in this study. |
| Key secondary outcomes | (i) comparison of the RBO factors between the benign and malignant groups; (ii) resolution of the risk factors for RBO in the benign and malignant groups; and (iii) evaluation of the risk factors in each disease. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Consecutive patients with suspected hepatobiliary-pancreatic disorders who underwent EBD attempts were retrospectively included in this study.
2. Performance status; 0,1,2. 3. More than 20 years old. 4. All patients provided written informed consent to undergo EBD |
|||
| Key exclusion criteria | Opt out method was adopted, and when the patients who underwent EBD reject to enrole in this study, the data will delete. The other drainage(i.e. pancreatic duct drainage, Duodenal stent) was also excleded. | |||
| Target sample size | 2156 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | The Jikei University School of Medicine | ||||||
| Division name | Department of Endoscopy | ||||||
| Zip code | 105-8461 | ||||||
| Address | 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo | ||||||
| TEL | 03-3433-1111(3181) | ||||||
| ccl09720@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | The Jikei University School of Medicine | ||||||
| Division name | Department of Endoscopy | ||||||
| Zip code | 105-8461 | ||||||
| Address | 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo | ||||||
| TEL | 03-3433-1111(2134) | ||||||
| Homepage URL | |||||||
| ccl09720@gmail.com | |||||||
| Sponsor | |
| Institute | Department of Endoscopy, The Jikei University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Endoscopy, The Jikei University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Ethics committee of The Jikei University School of Medicine for Biomedical Research |
| Address | 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo |
| Tel | 03-3433-1111(2134) |
| rinri@jikei.ac.jp | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | 31-099(9598) |
| Org. issuing International ID_1 | The Ethics committee of The Jikei University School of Medicine for Biomedical Research |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://www.nature.com/articles/s41598-020-70081-3#citeas |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://www.nature.com/articles/s41598-020-70081-3#citeas | ||||||
| Number of participants that the trial has enrolled | 2156 | ||||||
| Results | Chiba, M., Kato, M., Kinoshita, Y. et al. Best period to replace or change plastic stents with self-expandable metallic stents using multivariate competing risk regression analysis. Sci Rep 10, 13080 (2020). https://doi.org/10.1038/s41598-020-70081-3 |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | Chiba, M., Kato, M., Kinoshita, Y. et al. Best period to replace or change plastic stents with self-expandable metallic stents using multivariate competing risk regression analysis. Sci Rep 10, 13080 (2020). https://doi.org/10.1038/s41598-020-70081-3 |
||||||
| Participant flow | Chiba, M., Kato, M., Kinoshita, Y. et al. Best period to replace or change plastic stents with self-expandable metallic stents using multivariate competing risk regression analysis. Sci Rep 10, 13080 (2020). https://doi.org/10.1038/s41598-020-70081-3 |
||||||
| Adverse events | Chiba, M., Kato, M., Kinoshita, Y. et al. Best period to replace or change plastic stents with self-expandable metallic stents using multivariate competing risk regression analysis. Sci Rep 10, 13080 (2020). https://doi.org/10.1038/s41598-020-70081-3 |
||||||
| Outcome measures | Chiba, M., Kato, M., Kinoshita, Y. et al. Best period to replace or change plastic stents with self-expandable metallic stents using multivariate competing risk regression analysis. Sci Rep 10, 13080 (2020). https://doi.org/10.1038/s41598-020-70081-3 |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | The present retrospective cohort study was investigated the period to recurrent biliary obstruction after plastic stent placement. This study complied with the TOKYO criteria 2014 for a time to event analysis and with the other guidelines on survival analyses |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042910 |